Impact of timing on protection of combined immunoprophylaxis in preventing mother-to-child transmission of hepatitis B virus: a retrospective study

References

• Chinese Association of Hepatology, Chinese Association of Infectious Diseases. Guidelines for prevention and treatment of chronic hepatitis B (2022 edition) (in Chinese). Chin J Hepatol. 2022;30(12):1309–1331.
   PubMedGoogle Scholar
• Seto WK, Lo YR, Pawlotsky JM, et al. Chronic hepatitis B virus infection. Lancet. 2018;392(10161):2313–2324. doi: 10.1016/S0140-6736(18)31865-8.
   PubMed Web of Science ®Google Scholar
• Lou HQ, Zhu JH, Wang ZH, et al. Real-world effectiveness of immunoprophylaxis of mother-to-child transmission of hepatitis B virus based on pregnant women population. Chin J Perinatal Med. 2019;22(8):591–596.
   Google Scholar
• Huixia Y, Yari H, Xinghui L, et al. Clinical guidelines for prevention of mother-to-child transmission of hepatitis B virus (2020). Chin J Obstet Gynecol. 2020;5(55):291–299.
   Google Scholar
• Cheung KW, Seto M, Kan A, et al. Immunoprophylaxis failure of infants born to hepatitis B carrier mothers following routine vaccination. Clin Gastroenterol Hepatol. 2018;16(1):144–145. doi: 10.1016/j.cgh.2017.07.013.
   PubMed Web of Science ®Google Scholar
• Qiao YP, Su M, Song Y, et al. Outcomes of the national programme on prevention of mother-to-child transmission of hepatitis B virus in China, 2016-2017. Infect Dis Poverty. 2019;8(1):65. doi: 10.1186/s40249-019-0576-y.
   PubMed Web of Science ®Google Scholar
• Yh Z. Issues meriting further study in preventing mother-to-infant transmission of hepatitis B by antiviral therapy during pregnancy. Maternal Fetal Med. 2019;1(1):43–47.
   Google Scholar
• Mm J. Hepatitis B and pregnancy: an underestimated issue. Liver Int. 2009;29(Suppl. 1):133–139.
   Google Scholar
• Wiseman E, Fraser MA, Holden S, et al. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust. 2009;190(9):489–492. doi: 10.5694/j.1326-5377.2009.tb02524.x.
   PubMed Web of Science ®Google Scholar
• Jourdain G, Ngo-Giang-Huong N, Harrison L, et al. Tenofovir versus placebo to prevent perinatal transmission of hepatitis B. N Engl J Med. 2018;378(10):911–923. doi: 10.1056/NEJMoa1708131.
   PubMed Web of Science ®Google Scholar
• Huang H, Xu C, Liu L, et al. Increased protection of earlier use of immunoprophylaxis in preventing perinatal transmission of hepatitis B virus. Clin Infect Dis. 2021;73(9):e3317–e3323. doi: 10.1093/cid/ciaa898.
   PubMed Web of Science ®Google Scholar
• Hu Y, Xu C, Xu B, et al. Safety and efficacy of telbivudine in late pregnancy to prevent mother-to-child transmission of hepatitis B virus: a multicenter prospective cohort study. J Viral Hepat. 2018;25(4):429–437. doi: 10.1111/jvh.12834.
   PubMed Web of Science ®Google Scholar
• Zhang H, Pan CQ, Pang Q, et al. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice. Hepatology. 2014;60(2):468–476. doi: 10.1002/hep.27034.
   PubMed Web of Science ®Google Scholar
• Chen HL, Lee CN, Chang CH, et al. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus. Hepatology. 2015;62(2):375–386. doi: 10.1002/hep.27837.
   PubMed Web of Science ®Google Scholar
• Pan CQ, Duan Z, Dai E, et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N Engl J Med. 2016;374(24):2324–2334. doi: 10.1056/NEJMoa1508660.
   PubMed Web of Science ®Google Scholar
• Greenup AJ, Tan PK, Nguyen V, et al. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus. J Hepatol. 2014;61(3):502–507. doi: 10.1016/j.jhep.2014.04.038.
   PubMed Web of Science ®Google Scholar
• Huang H, Ning M, Liu J, et al. Comparison of antibody response to hepatitis B vaccination in infants with positive or negative maternal hepatitis B e antigen (HBeAg) in cord blood: implication for the role of HBeAg as an immunotolerogen. Hum Vaccin Immunother. 2019;15(9):2183–2186. doi: 10.1080/21645515.2019.1575712.
   PubMed Web of Science ®Google Scholar
• Hu Y, Zhang S, Luo C, et al. Gaps in the prevention of perinatal transmission of hepatitis B virus between recommendations and routine practices in a highly endemic region: a provincial population-based study in China. BMC Infect Dis. 2012;12(1):221. doi: 10.1186/1471-2334-12-221.
   PubMedGoogle Scholar
• Nguyen TH, Vu MH, Nguyen VC, et al. A reduction in chronic hepatitis B virus infection prevalence among children in Vietnam demonstrates the importance of vaccination. Vaccine. 2014;32(2):217–222. doi: 10.1016/j.vaccine.2013.11.004.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Assessing completeness of perinatal hepatitis B virus infection reporting through comparison of immunization program and surveillance data–United States. MMWR Morb Mortal Wkly Rep. 2011;60(13):410–413.
   PubMedGoogle Scholar
• Zou H, Chen Y, Duan Z, et al. Protective effect of hepatitis B vaccine combined with two-dose hepatitis B immunoglobulin on infants born to HBsAg-positive mothers. PLoS One. 2011;6(10):e26748. doi: 10.1371/journal.pone.0026748.
   PubMed Web of Science ®Google Scholar
• Tan Z, Yin Y, Zhou J, et al. Telbivudine treatment of hepatitis B virus-infected pregnant women at different gestational stages for the prevention of mother-to-child transmission: outcomes of telbivudine treatment during pregnancy. Medicine. 2016;95(40):e4847. doi: 10.1097/MD.0000000000004847.
   PubMed Web of Science ®Google Scholar
• Pan CQ, Yi W, Liu M, et al. Lamivudine therapy during the second vs the third trimester for preventing transmission of chronic hepatitis B. J Viral Hepat. 2017;24(3):246–252. doi: 10.1111/jvh.12640.
   PubMed Web of Science ®Google Scholar
• Visvanathan K, Dusheiko G, Giles M, et al. Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders. Gut. 2016;65(2):340–350. doi: 10.1136/gutjnl-2015-310317.
   PubMed Web of Science ®Google Scholar
• Mavilia MG, Wu GY. Mechanisms and prevention of vertical transmission in chronic viral hepatitis. J Clin Transl Hepatol. 2017;5(2):119–129. doi: 10.14218/JCTH.2016.00067.
   PubMed Web of Science ®Google Scholar
• Aslam A, Ishtiaq R, Lau DTY. Timely administration of birth dose hepatitis B virus vaccine may break the chain of perinatal transmission. Hepatology. 2019;69(5):2284–2286. doi: 10.1002/hep.30332.
   PubMed Web of Science ®Google Scholar
• Sun K-X, Li J, Zhu F-C, et al. A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women. Vaccine. 2012;30(36):5335–5340. doi: 10.1016/j.vaccine.2012.06.036.
   PubMed Web of Science ®Google Scholar
• Wen WH, Chang MH, Zhao LL, et al. Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention. J Hepatol. 2013;59(1):24–30. doi: 10.1016/j.jhep.2013.02.015.
   PubMed Web of Science ®Google Scholar
• Liu J, Bi Y, Xu C, et al. Kinetic changes of viremia and viral antigens of hepatitis B virus during and after pregnancy. Medicine. 2015;94(45):e2001. doi: 10.1097/MD.0000000000002001.
   PubMed Web of Science ®Google Scholar
• Schillie S, Walker T, Veselsky S, et al. Outcomes of infants born to women infected with hepatitis B. Pediatrics. 2015;135(5):e1141–e1147. doi: 10.1542/peds.2014-3213.
   PubMed Web of Science ®Google Scholar
• Kubo A, Shlager L, Marks AR, et al. Prevention of vertical transmission of hepatitis B: an observational study. Ann Intern Med. 2014;160(12):828–835. doi: 10.7326/M13-2529.
   PubMed Web of Science ®Google Scholar
• Yin Y, Wu L, Zhang J, et al. Identification of risk factors associated with immunoprophylaxis failure to prevent the vertical transmission of hepatitis B virus. J Infect. 2013;66(5):447–452. doi: 10.1016/j.jinf.2012.12.008.
   PubMed Web of Science ®Google Scholar